Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Nestlé_Skin_Health
gptkb:Allergan_Aesthetics gptkb:Cetaphil |
| gptkbp:acquired |
Aesthetics business from Merz
Q-Med |
| gptkbp:acquisition |
Merz Pharmaceuticals
|
| gptkbp:awards |
multiple industry awards
|
| gptkbp:clinical_trial |
conducts numerous
|
| gptkbp:employees |
over 3,000
|
| gptkbp:focus |
skin health
|
| gptkbp:founded |
gptkb:1981
|
| gptkbp:founder |
gptkb:Nestlé
|
| gptkbp:headquarters |
gptkb:Lausanne,_Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Galderma
|
| gptkbp:industry |
dermatology
|
| gptkbp:market |
strong in Europe
strong in North America strong in Asia |
| gptkbp:operates_in |
over 100 countries
|
| gptkbp:parent_company |
gptkb:EQT_Partners
|
| gptkbp:partnership |
with various dermatology organizations
|
| gptkbp:products |
gptkb:Differin
Restylane Sculptra |
| gptkbp:research |
gptkb:Dr._John_Doe
|
| gptkbp:research_and_development |
invests heavily
|
| gptkbp:website |
www.galderma.com
|